Skip to content
Open access

326. Ketamine-induced changes of cerebral glucose metabolism in healthy humans: evidence from [18F]FDG functional PET

Sep 2026 · International Journal of Neuropsychopharmacology · Vol 29, pp. i136 - i136 · 0 citations

TL;DR

The findings provide metabolic sensitive insight into ketamine’s impact on neuronal function and synchronous, temporally dynamic metabolic changes may contribute to ketamine’s rapid-onset and transient neuropsychological effects.

Abstract

Abstract Background Ketamine is a N-methyl-D-aspartate receptor antagonist with rapid-acting antidepressant properties and characteristic dissociative side effects, yet its neuronal mechanisms remain only partially understood. Previous studies have primarily used pharmacological magnetic resonance imaging (phMRI) to characterize ketamine-induced neuronal alterations (Höflich et al., 2017; Maltbie, Kaundinya, & Howell, 2017). Allthough phMRI offer high temporal and spatial resolution, neuronal activity is assessed indirectly via oxygen metabolism, and neurovascular factors (Doyle et al., 2013; J.L. Reed et al., 2019). In contrast, functional PET (fPET) with [18F]Fluorodeoxyglucose ([18F]FDG) offer a complementary and direct measure (Leybaert, 2005), to quantify cerebral glucose metabolism. Previous studies using [18F]FDG PET to investigate ketamine’s neurophysiological effect, have been restricted to static metabolic rates (Vollenweider et al., 1997), thereby being unable to assess its dynamic effects. Aims & Objectives We aimed to capture acute ketamine-induced changes in cerebral glucose metabolism within a functional PET (fPET) framework. Method In this double-blind, randomized, cross-over study twenty-three healthy volunteers (mean age ± SD = 25.48 ± 4.08 years, 14 male) underwent two 75-minute [18F]FDG simultaneous PET/MR scans, during which they received either 0.25mg*kg-1 (S)-ketamine or a 0.9% saline placebo intravenously. 20 minutes after tracer application and fPET acquisition start, the study drug was administred following a block design comprising three 5-minutes infusion blocks separated by 10-minute drug-free intervals. fPET data were reconstructed into 30 seconds frames and preprocessed as described previously (M.B. Reed et al., 2024). Baseline-corrected [18F]FDG time activity curves were obtained across grey-matter voxels, capturing drug-induced changes in cerebral glucose metabolism, and used for a voxel-wise intersubject correlation analysis, and subsequent comparison between conditions in a repeated measures ANOVA (p < 0.05, FWE-corrected). Results Ketamine induced widespread and significantly increased cortical intersubject correlations, most predominantly in frontal cortical regions and the right hippocampus. The nine most significant regions and highest T-values are displayed in the Table below. Discussion & Conclusions (S)-Ketamine administration elicited metabolic responses primarily within hubs of the default mode and frontoparietal control network, with additional but fewer clusters in regions associated with the visual, sensorimotor and salience networks. These synchronous, temporally dynamic metabolic changes may contribute to ketamine’s rapid-onset and transient neuropsychological effects. In summary, our findings provide metabolic sensitive insight into ketamine’s impact on neuronal function.

Read PDF

Similar papers

Open access Sep 2026

Pharmacological and non-pharmacological modulation of striatal dopamine release: a meta-analysis of [11C]raclopride PET studies.

The dopaminergic system has long been a central focus of functional neuroimaging. Positron emission tomography (PET) with the D2/D3 receptor radioligand [11C]raclopride remains the most widely used method for indirectly quantifying striatal dopamine release in vivo. However, no previous meta-analysis has studied the re...

Mikael Eklund, Eman Hassanain, T. Vahlberg et al. · 0 citations
Open access Sep 2026

A multimodal investigation of altered cortical metabolism in patients with disorders of consciousness

Disorders of consciousness (DoC) are characterised by marked reductions in cerebral glucose metabolism, but the specific cellular and neurochemical processes driving this impairment remain unclear. To elucidate these mechanisms, a multimodal imaging approach combining [18F]-fluorodeoxyglucose positron emission tomograp...

N. W. Duncan, L. Huang, C. Lee et al. · 0 citations
Aug 2026

In Vivo Rodent Studies with the Novel PET Tracer [18F]PGM028299: An Inhibitor of D-Amino Acid Oxidase.

Abnormal N-methyl-d-aspartate receptor (NMDAr) function is implicated in schizophrenia and other neuropsychiatric disorders. Enhancing NMDAr signaling can be achieved by increasing synaptic d-serine levels through the inhibition of D-amino acid oxidase (DAAO). We report the synthesis and preclinical evaluation of [18F]...

M. Onega, Eimear Howley, Charlotte Fieldhouse et al. · 0 citations
Open access Sep 2026

451. Investigating synaptic density in youth with cannabis use: preliminary findings from a [18F]SynVesT-1 PET imaging study

Abstract Background Adolescence is a key period for neurodevelopment, marked by synaptic pruning. Preclinical studies show that repeated cannabinoid exposure can alter synaptic structure and synaptic protein markers (Oliva et al., 2024; Rubino et al., 2015). In adults, chronic cannabis use has been linked to lower syna...

C. Côté, M. Zilberman, S. S. Dheda et al. · 0 citations
Open access Aug 2026

Age-Related Decline in Anterior Cingulate and Medial Prefrontal Metabolism in Nonneurodegenerative Patients: An 18 F-FDG PET Study

Abstract Objective 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography (PET) is widely used to evaluate patients with cognitive complaints, particularly to differentiate neurodegenerative disorders. However, memory impairment may arise from various nonneurodegenerative conditions, including metabolic, psyc...

Reyhan Toyran, Yiğithan Okar, Ayşe Rana Ovut et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.